Search Results - "Wong, Risa"

The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer by Nipp, Ryan D., El‐Jawahri, Areej, Moran, Samantha M., D'Arpino, Sara M., Johnson, P. Connor, Lage, Daniel E., Wong, Risa L., Pirl, William F., Traeger, Lara, Lennes, Inga T., Cashavelly, Barbara J., Jackson, Vicki A., Greer, Joseph A., Ryan, David P., Hochberg, Ephraim P., Temel, Jennifer S.

“…BACKGROUND Patients with advanced cancer often experience frequent and prolonged hospitalizations; however, the factors associated with greater health care…”
Get full text

Enfortumab vedotin in the treatment of urothelial cancers and beyond by Wong, Risa L, Yu, Evan Y

“…Enfortumab vedotin (EV) is the first antibody–drug conjugate approved for locally advanced or metastatic urothelial cancers (la/mUCs), a disease group…”
Get full text

Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations by Wong, Risa L., Yu, Evan Y.

“…Opinion statement Due to its immunosuppressive tumor microenvironment, prostate cancer has historically been difficult to treat with immuno-oncology…”
Get full text

Symptoms of posttraumatic stress disorder among hospitalized patients with cancer by Nipp, Ryan D., El‐Jawahri, Areej, D'Arpino, Sara M., Chan, Andy, Fuh, Charn‐Xin, Johnson, P. Connor, Lage, Daniel E., Wong, Risa L., Pirl, William F., Traeger, Lara, Cashavelly, Barbara J., Jackson, Vicki A., Ryan, David P., Hochberg, Ephraim P., Temel, Jennifer S., Greer, Joseph A.

“…BACKGROUND Patients with cancer experience many stressors placing them at risk for posttraumatic stress disorder (PTSD) symptoms, yet little is known about…”
Get full text

Implementing a Palliative Care Junior Faculty Visiting Professor Program: Pearls and Pitfalls by Seaman, Jennifer B., Thomas, Teresa H., Wong, Risa L., Lazris, David I., Belin, Maria, Schenker, Yael

“…Motivation Palliative Care (PC) is a small, relatively young interprofessional sub-specialty; hence mentorship for early-career research faculty is widely…”
Get full text

Race and surgical residency: results from a national survey of 4339 US general surgery residents by Wong, Risa L, Sullivan, Michael C, Yeo, Heather L, Roman, Sanziana A, Bell, Jr, Richard H, Sosa, Julie A

“…To determine how race influences US general surgery residents' experiences during residency training. Minorities are underrepresented in medicine, particularly…”
Get full text

Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers by Wong, Risa L., Morgans, Alicia K.

“…Purpose of Review Patient reported outcomes (PROs) are increasingly utilized in cancer drug development, and are of particular importance in genitourinary…”
Get full text

Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney by Wong, Risa L., Ketcham, Megan, Irwin, Trent, Akilesh, Shreeram, Zhang, Tian Yi, Reyes, Jorge D., Edlefsen, Kerstin, Jalikis, Florencia, Becker, Pamela S.

Get full text

Predictors of Posthospital Transitions of Care in Patients With Advanced Cancer by Lage, Daniel E, Nipp, Ryan D, D'Arpino, Sara M, Moran, Samantha M, Johnson, P Connor, Wong, Risa L, Pirl, William F, Hochberg, Ephraim P, Traeger, Lara N, Jackson, Vicki A, Cashavelly, Barbara J, Martinson, Holly S, Greer, Joseph A, Ryan, David P, Temel, Jennifer S, El-Jawahri, Areej

“…Purpose Patients with advanced cancer experience potentially burdensome transitions of care after hospitalizations. We examined predictors of discharge…”
Get full text

Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum‐Based Chemotherapy for Metastatic Disease by Wong, Risa L., Ferris, Lorin A., Do, Olivia A., Holt, Sarah K., Ramos, Jorge D., Crabb, Simon J., Sternberg, Cora N., Bellmunt, Joaquim, Ladoire, Sylvain, De Giorgi, Ugo, Harshman, Lauren C., Vaishampayan, Ulka N., Necchi, Andrea, Srinivas, Sandy, Pal, Sumanta K., Niegisch, Guenter, Dorff, Tanya B., Galsky, Matthew D., Yu, Evan Y.

“…Background Fit patients with metastatic urothelial carcinoma (mUC) receive first‐line platinum‐based combination chemotherapy (fPBC) as standard of care and…”
Get full text

Weight change in heart failure inpatients not associated with 30-day readmission by Nanna, Michael G, Sullivan, Alexander E, Bazylevska, Vlada, L Wong, Risa, Murphy, Terrence E, Bellumkonda, Lavanya, McNamara, Robert L

“…The association of weight change and short-term readmission in patients hospitalized for heart failure (HF) has not been well studied. We collected clinical…”
Get full text

Survival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer by Wong, Risa L., Duong, Mai T., Tangen, Catherine M., Agarwal, Neeraj, Cheng, Heather H., Vogelzang, Nicholas J., Hussain, Maha, Thompson, Ian M., Quinn, David I., Yu, Evan Y.

“…Background Cixutumumab, a monoclonal antibody targeting insulin-like growth factor I receptor, did not improve undetectable prostate-specific antigen (PSA)…”
Get full text

Simultaneous Medullary and Differentiated Thyroid Cancer: A Population-Level Analysis of an Increasingly Common Entity by Wong, Risa L., Kazaure, Hadiza S., Roman, Sanziana A., Sosa, Julie A.

“…Background Simultaneous medullary thyroid carcinoma (MTC) and differentiated thyroid carcinoma (DTC) is a rare entity. This is the first population-level…”
Get full text

Use of Antidepressant Medications Moderates the Relationship Between Depressive Symptoms and Hospital Length of Stay in Patients with Advanced Cancer by Wong, Risa L, El‐Jawahri, Areej, D'Arpino, Sara M, Fuh, Charn‐Xin, Johnson, P. Connor, Lage, Daniel E, Irwin, Kelly E, Pirl, William F, Traeger, Lara, Cashavelly, Barbara J, Jackson, Vicki A, Greer, Joseph A, Ryan, David P, Hochberg, Ephraim P, Temel, Jennifer S, Nipp, Ryan D

“…Background Among patients with cancer, depressive symptoms are associated with worse clinical outcomes, including greater health care utilization. As use of…”
Get full text

Gaps in Public Awareness About BRCA and Genetic Testing in Prostate Cancer: Social Media Landscape Analysis by Loeb, Stacy, Massey, Philip, Leader, Amy E, Thakker, Sameer, Falge, Emily, Taneja, Sabina, Byrne, Nataliya, Rose, Meredith, Joy, Matthew, Walter, Dawn, Katz, Matthew S, Wong, Risa L, Selvan, Preethi, Keith, Scott W, Giri, Veda N

“…Genetic testing, particularly for BRCA1/2, is increasingly important in prostate cancer (PCa) care, with impact on PCa management and hereditary cancer risk…”
Get full text

Benefits, Harms, and Stakeholder Perspectives Regarding Opioid Therapy for Pain in Individuals With Metastatic Cancer: Protocol for a Descriptive Cohort Study by Jones, Katie Fitzgerald, White, Gretchen, Bennett, Antonia, Bulls, Hailey, Escott, Paula, Orris, Sarah, Escott, Elizabeth, Fischer, Stacy, Hamm, Megan, Krishnamurti, Tamar, Wong, Risa, LeBlanc, Thomas W, Liebschutz, Jane, Meghani, Salimah, Smith, Cardinale, Temel, Jennifer, Ritchie, Christine, Merlin, Jessica S

“…Opioids are a key component of pain management among patients with metastatic cancer pain. However, the evidence base available to guide opioid-related…”
Get full text

Randomized trial of early integrated palliative and oncology care by Temel, Jennifer S., El-Jawahri, Areej, Greer, Joseph A., Pirl, William F., Jackson, Vicki A., Park, Elyse R., Back, Anthony, Muzikansky, Alona, Kamdar, Mihir M., Rinaldi, Simone, Jacobsen, Juliet, Wong, Risa, Nipp, Ryan David, Gallagher, Emily R., Fishbein, Joel, Eusebio, Justin, VanDusen, Harry, Ryan, David P.

“…Abstract only…”
Get full text

Potentially Avoidable Hospital Readmissions in Patients With Advanced Cancer by Johnson, P Connor, Xiao, Yian, Wong, Risa L, D'Arpino, Sara, Moran, Samantha M C, Lage, Daniel E, Temel, Brandon, Ruddy, Margaret, Traeger, Lara N, Greer, Joseph A, Hochberg, Ephraim P, Temel, Jennifer S, El-Jawahri, Areej, Nipp, Ryan D

“…Patients with cancer often prefer to avoid time in the hospital; however, data are lacking on the prevalence and predictors of potentially avoidable…”
Get full text

Differences in real-world pembrolizumab dosing patterns (every 3 weeks versus every 6 weeks) across a large cancer center network by Natesan, Divya, Chablani, Priyanka Vinod, Wang, Hong, Jelinek, Mark, Rosenzweig, Margaret Q., Wong, Risa Liang

“…2592 Background: Pembrolizumab (pembro) is an intravenous immune checkpoint inhibitor used for anti-cancer treatment, with equivalent monotherapy dosing…”
Get full text

Longitudinal variability in symptom burden for patients with prostate cancer (PC) by Wong, Risa Liang, Cheng, Heather H., Fann, Jesse R., Hnida, James, Chakoian, Marty, Jannat, Samia, Schenker, Yael, Yu, Evan Y., Gore, John L.

“…e17019 Background: Patients with PC often live for many years and can experience burdensome symptoms associated with PC and its treatment. The longitudinal…”
Get full text